Table 5, Strengths and Limitations of Guideline using AGREE II - Cooling for Thermal Burns: Clinical Effectiveness and Guidelines

Item	Guideline
Domain 1: Scope and Purpose
1. The overall objective(s) of the guideline is (are) specifically described.	Yes
2. The health question(s) covered by the guideline is (are) specifically described.	Yes
3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described.	Yes
Domain 2: Stakeholder Involvement
4. The guideline development group includes individuals from all relevant professional groups.	Yes
5. The views and preferences of the target population (patients, public, etc.) have been sought.	Yes
6. The target users of the guideline are clearly defined.	Yes
Domain 3: Rigour of Development
7. Systematic methods were used to search for evidence.	Yes
8. The criteria for selecting the evidence are clearly described.	Unclear
9. The strengths and limitations of the body of evidence are clearly described.	Yes
10. The methods for formulating the recommendations are clearly described.	Yes
11. The health benefits, side effects, and risks have been considered in formulating the recommendations.	Yes
12. There is an explicit link between the recommendations and the supporting evidence.	Yes
13. The guideline has been externally reviewed by experts prior to its publication.	Yes
14. A procedure for updating the guideline is provided.	Yes
Domain 4: Clarity of Presentation
15. The recommendations are specific and unambiguous.	Yes
16. The different options for management of the condition or health issue are clearly presented.	Yes
17. Key recommendations are easily identifiable.	Yes
Domain 5: Applicability
18. The guideline describes facilitators and barriers to its application.	Yes
19. The guideline provides advice and/or tools on how the recommendations can be put into practice.	Yes
20. The potential resource implications of applying the recommendations have been considered.	No
21. The guideline presents monitoring and/or auditing criteria.	Yes
Domain 6: Editorial Independence
22. The views of the funding body have not influenced the content of the guideline.	Yes
23. Competing interests of guideline development group members have been recorded and addressed.	Yes

Item

Guideline

DynaMed Plus 2018⁶

Domain 1: Scope and Purpose

1. The overall objective(s) of the guideline is (are) specifically described.

Yes

2. The health question(s) covered by the guideline is (are) specifically described.

Yes

3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described.

Yes

Domain 2: Stakeholder Involvement

4. The guideline development group includes individuals from all relevant professional groups.

Yes

5. The views and preferences of the target population (patients, public, etc.) have been sought.

Yes

6. The target users of the guideline are clearly defined.

Yes

Domain 3: Rigour of Development

7. Systematic methods were used to search for evidence.

Yes

8. The criteria for selecting the evidence are clearly described.

Unclear

9. The strengths and limitations of the body of evidence are clearly described.

Yes

10. The methods for formulating the recommendations are clearly described.

Yes

11. The health benefits, side effects, and risks have been considered in formulating the recommendations.

Yes

12. There is an explicit link between the recommendations and the supporting evidence.

Yes

13. The guideline has been externally reviewed by experts prior to its publication.

Yes

14. A procedure for updating the guideline is provided.

Yes

Domain 4: Clarity of Presentation

15. The recommendations are specific and unambiguous.

Yes

16. The different options for management of the condition or health issue are clearly presented.

Yes

17. Key recommendations are easily identifiable.

Yes

Domain 5: Applicability

18. The guideline describes facilitators and barriers to its application.

Yes

19. The guideline provides advice and/or tools on how the recommendations can be put into practice.

Yes

20. The potential resource implications of applying the recommendations have been considered.

21. The guideline presents monitoring and/or auditing criteria.

Yes

Domain 6: Editorial Independence

22. The views of the funding body have not influenced the content of the guideline.

Yes

23. Competing interests of guideline development group members have been recorded and addressed.

Yes

From: Cooling for Thermal Burns: Clinical Effectiveness and Guidelines

Cover of Cooling for Thermal Burns: Clinical Effectiveness and Guidelines

Cooling for Thermal Burns: Clinical Effectiveness and Guidelines [Internet].

Sutton D, Wright MD.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan 17.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Table 5Strengths and Limitations of Guideline using AGREE II